StockWatch
·

WOCKHARDT LTD. Q2 FY27 Results

WOCKPHARMAQ2 FY27 Results
Filing
Result:Weak· Market: Flat#Cost led#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue969.004.3%23.9%
Total Income980.002.1%22.0%
Expenditure907.007.5%27.4%
PBT73.0037.1%19.8%
Net Profit73.0031.8%11.0%
OPM—
NPM7.45%3.70pp2.76pp
EPS4.8525.9%0.8%
View full financials

Pharma's core profitability metric (adjusted PAT) fell 11% YoY and EBITDA margin compressed ~490bps as raw-material costs outran strong 23.9% revenue growth, a cost-led squeeze driven by international/generics subsidiaries rather than the India business.

Q2 FY-2027 RESULTS · WOCKPHARMA

Wockhardt Q2 FY27: consolidated PAT falls 11% YoY to ₹73 Cr as units abroad swing to loss

PAT -10.98% YoY · revenue +23.91% · margins compressing

02 Nov 2026 · 3 min read
Revenue

₹969 Cr

+23.91% YoY

PAT (consolidated)

₹73 Cr

-10.98% YoY

Net margin

7.45%

-2.8pp YoY

EPS

₹4.85

Wockhardt's consolidated (primary basis) revenue rose 23.9% YoY and 4.3% QoQ to ₹969 Cr, but consolidated net profit fell 11.0% YoY and 31.8% QoQ to ₹73 Cr, down from ₹107 Cr in Q1 FY27 and ₹82 Cr a year ago. That YoY profit decline despite strong topline growth is the headline: this was a margin-compression quarter, not a growth miss. The standalone (India) business tells almost the opposite story — standalone revenue jumped 52.6% YoY to ₹580 Cr and standalone PAT surged 85.2% YoY to ₹100 Cr, roughly in line with Q1's ₹107 Cr. The >3% divergence between the two bases is real and traceable: implied subsidiary-level profit (consolidated PAT minus standalone PAT) swung from +₹28 Cr a year ago and roughly breakeven last quarter to a ~₹27 Cr loss this quarter, even as implied subsidiary revenue held broadly flat (₹389 Cr vs ₹402 Cr YoY). The international/generics subsidiaries, not the India business, drove the miss.

The scoreboard

Q2 FY-2027 vs prior quarters

Consolidated P&L, ₹ Crore
Q2 FY-2027QoQYoY
Revenue₹969 Cr+4.3%+23.9%
Expenses₹907 Cr+7.5%+27.4%
PAT₹73 Cr-31.78%-10.98%
Net margin7.45%-3.7pp-2.8pp
EPS₹4.85-26%+0.8%

The margin bridge confirms it: consolidated operating margin (EBITDA/revenue from operations) compressed to 17.85% from 22.76% a year ago and 20.67% last quarter — roughly a 490bps YoY and 280bps QoQ hit — while net margin (PAT/total income) fell to 7.45% from 10.21% YoY and 11.15% QoQ. The combined cost of materials and purchased goods (net of inventory movement) rose to about 35.2% of revenue from 29.8% a year ago, the single largest driver, with other expenses also running higher as a share of sales (27.1% vs 26.0% YoY). Finance costs (₹56 Cr) and depreciation (₹55 Cr) were both broadly flat YoY and QoQ, so the squeeze sits entirely in operating costs, not below-the-line items. One offsetting nuance: because non-controlling interest absorbed a ₹6 Cr loss this quarter (vs a ₹4 Cr profit a year ago and ₹1 Cr last quarter), PAT attributable to Wockhardt's own shareholders (₹79 Cr) held up far better than total PAT — down just ~1.3% YoY and basic EPS was effectively flat at ₹4.85 against ₹4.81 a year ago, even though total consolidated PAT fell double digits.

₹
1,738.341,902.022,065.72,229.382,393.061,89507-3008-2109-1510-0811-02Q2 FY-2027 results
The tape into the print — daily closes, last 3 months

The stock went into the print at ₹1,895, down 10.5% over the past month of trading.

₹ Cr
-140.64-28.2184.21196.64-108Q1 FY26rev ₹738 Cr82Q2 FY26rev ₹782 Cr61Q3 FY26rev ₹888 Cr164Q4 FY26rev ₹965 Cr107Q1 FY27rev ₹929 Cr73Q2 FY27rev ₹969 Cr
Quarterly consolidated PAT, ₹ Crore

For context: revenue is at a 6-quarter high.

No consensus estimates for this specific quarter turned up in a search, and the comparison context carries no prior management guidance or concall read on record, so this cannot be graded against a Street number or a stated outlook — management gives no formal guidance on this print. Among the quarter's corporate developments, the company confirmed on August 10 that QIP proceeds utilization showed no deviation, consistent with continued capex/pipeline build: consolidated intangible assets under development rose to ₹1,743 Cr (from ₹1,708 Cr at FY26-end) and capital work-in-progress stood at ₹676 Cr. Separately, Wockhardt was fined ₹15 Cr by Customs on August 25 for API mis-classification; since the filing shows no exceptional item this quarter, that fine — if absorbed — would sit inside the regular expense lines rather than being called out, which the company has not done explicitly.

  • W1

    Whether the implied subsidiary-level loss (~₹27 Cr this quarter vs +₹28 Cr a year ago) reverses next quarter

  • W2

    Operating margin trajectory — compressed to 17.85% this quarter from 22.76% a year ago; watch if the materials/purchased-goods cost ratio (~35% of revenue vs ~30% a year ago) normalizes

  • W3

    Commercialization/payback timeline on the ₹1,743 Cr consolidated intangible-assets-under-development pipeline, funded in part via the QIP whose proceeds utilization was confirmed on-track on August 10

Tax nets to zero both bases (current tax ₹4 Cr offset by deferred tax credit ₹4 Cr, consolidated). No exceptional items this quarter or in the Q2 FY26 base, so YoY/QoQ are on a clean basis. Consolidated PAT attributable to equity shareholders was ₹79 Cr (vs total ₹73 Cr) because non-controlling interest swung to a ₹6 Cr loss. Standalone and consolidated diverge sharply (+85% vs -11% YoY PAT) — flagged per basis rule. Document is clean, typed, unambiguous column headers.

Informational and educational content only. Not investment advice.